Skip to content

VERDE BIO HOLDINGS, INC.: 10-Q filed 2018-03-26

What VERDE BIO HOLDINGS, INC. reported in its quarterly report filed 2018-03-26 (fiscal Q3 2018): 18 published measures, 52 facts as tagged in accession 0001445866-18-000295.

This filing

Form
10-Q (quarterly report)
Filed
2018-03-26
Fiscal period
fiscal Q3 2018
Accession
0001445866-18-000295 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All VERDE BIO HOLDINGS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2018-01-3142,514USD
At 2017-04-3057,391USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2018-01-311,008,062USD
At 2017-04-301,606,676USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2018-01-31-965,548USD
At 2017-04-30-1,549,285USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2017-11-01 to 2018-01-31-197,831USD92
2017-05-01 to 2018-01-31-662,580USD276
2016-11-01 to 2017-01-31-12,903USD92
2016-05-01 to 2017-01-31-649,345USD276

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2017-05-01 to 2018-01-31-212,880USD276
2016-05-01 to 2017-01-31-185,274USD276

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2017-05-01 to 2018-01-31218,000USD276
2016-05-01 to 2017-01-31191,344USD276

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2018-01-31-4,576,829USD
At 2017-04-30-3,914,249USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2017-11-01 to 2018-01-31-92,771USD92
2017-05-01 to 2018-01-31-369,055USD276
2016-11-01 to 2017-01-31-131,777USD92
2016-05-01 to 2017-01-31-315,712USD276

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2017-11-01 to 2018-01-3123,587USD92
2017-05-01 to 2018-01-31155,070USD276
2016-11-01 to 2017-01-3141,116USD92
2016-05-01 to 2017-01-3154,210USD276

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2018-01-315,051USD
At 2017-04-301,773USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2017-11-01 to 2018-01-3198,097USD92
2017-05-01 to 2018-01-31387,584USD276
2016-11-01 to 2017-01-31150,347USD92
2016-05-01 to 2017-01-31348,432USD276

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2017-11-01 to 2018-01-315,326USD92
2017-05-01 to 2018-01-3118,529USD276
2016-11-01 to 2017-01-3118,570USD92
2016-05-01 to 2017-01-3132,720USD276

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2017-11-01 to 2018-01-318,624USD92
2017-05-01 to 2018-01-3123,321USD276
2016-11-01 to 2017-01-313,927USD92
2016-05-01 to 2017-01-3120,777USD276

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2018-01-3117,568,373shares
At 2017-04-302,738,069shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2018-01-313,606,623USD
At 2017-04-302,375,136USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2017-11-01 to 2018-01-316,099USD92
2017-05-01 to 2018-01-3172,380USD276
2016-11-01 to 2017-01-3118,237USD92
2016-05-01 to 2017-01-3147,337USD276

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2017-11-01 to 2018-01-31-105,060USD92
2017-05-01 to 2018-01-31-293,525USD276
2016-11-01 to 2017-01-31118,874USD92
2016-05-01 to 2017-01-31-333,633USD276

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2017-05-01 to 2018-01-31629USD276
2016-05-01 to 2017-01-3121,794USD276

Inspect the source

Entity
VERDE BIO HOLDINGS, INC. / CIK 0001490054
Captured
2026-09-19T11:18:19.126Z
SEC response SHA-256
dd7cd08239c5c2462afbc7dbecad94ca6a89142a02ded38321628f853eea98c8

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001490054.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))